Chidamide for Patients With Recurrent and Metastatic Epstein-Barr Virus (EBV)-Associated Solid Tumors
Clinical trial NCT03494634 · UNKNOWN
Trial details
- NCT number
- NCT03494634
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-15
- Primary completion
- 2019-09-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.